Mast Cell Protease 2 (MCP-2) activators comprise a diverse array of compounds primarily centered around stabilizing mast cells and modulating the release of mediators that can impact MCP-2 activity. Cromolyn Sodium, Nedocromil Sodium, and Sodium Cromoglicate exemplify this mechanism by their ability to stabilize mast cells, effectively reducing the release of granules that contain inhibitors of MCP-2. This action ensures a more consistent and elevated level of active MCP-2, essential in allergic reactions and other immune responses. Similarly, Ketotifen Fumarate and Azelastine, both antihistamines, contribute to MCP-2 activity enhancement by reducing histamine release and stabilizing mast cells, thus minimizing mediators that could potentially downregulate MCP-2. Additionally, compounds like Quercetin and Luteolin, known for their antioxidant properties, indirectly augment MCP-2 activity by reducing oxidative stress, a condition that can diminish MCP-2 function. Their mast cell stabilizing effect further aids in maintaining optimal MCP-2 levels.
Expanding beyond traditional mast cell stabilizers, compounds like Tranilast and Omalizumab represent a more targeted approach to enhancing MCP-2 activity. Tranilast, with its anti-allergic properties, limits the release of competing or inhibitory signals against MCP-2 in allergic responses. In contrast, Omalizumab, an anti-IgE antibody, indirectly maintains MCP-2 activity by preventing IgE-mediated mast cell degranulation, a key process in allergic reactions. This stabilization ensures that MCP-2 is not overwhelmed or inhibited by other cellular mediators. Further contributing to this mechanism, Epigallocatechin Gallate, a catechin from green tea, also stabilizes mast cells, which indirectly leads to increased MCP-2 activity by reducing the release of inhibitory mediators. Rupatadine, another antihistamine, echoes this theme by stabilizing mast cells and reducing histamine release, thereby supporting MCP-2 function. Collectively, these MCP-2 activators work through nuanced pathways to stabilize mast cell activity and optimize the presence and function of MCP-2 in various physiological and immunological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cromolyn disodium salt | 15826-37-6 | sc-207459 sc-207459A sc-207459B sc-207459C sc-207459D sc-207459E sc-207459F | 1 g 5 g 25 g 50 g 100 g 500 g 1 kg | $50.00 $174.00 $624.00 $1040.00 $1873.00 $2913.00 $3537.00 | ||
Cromolyn Sodium stabilizes mast cells, preventing degranulation. By inhibiting the release of MCP-2’s pro-activators from mast cells, this compound indirectly maintains higher active levels of MCP-2, as its natural inhibitors are less prevalent. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid, is known for its antioxidant properties and also stabilizes mast cells. It may indirectly increase MCP-2 activity by reducing oxidative stress, which can impair MCP-2 function. | ||||||
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $31.00 $103.00 $283.00 $978.00 | 2 | |
Tranilast, an anti-allergic compound, reduces the release of mast cell mediators. This action indirectly sustains MCP-2 activity by minimizing competitive or inhibitory signals against MCP-2 in allergic responses. | ||||||
Azelastine | 58581-89-8 | sc-337544 sc-337544A sc-337544B | 100 mg 500 mg 1 g | $220.00 $550.00 $700.00 | ||
Azelastine, an antihistamine, stabilizes mast cells and can indirectly support MCP-2 activity by reducing the release of histamine and other mediators that might downregulate MCP-2. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate, a type of catechin found in green tea, has been shown to stabilize mast cells, potentially leading to an indirect increase in MCP-2 activity by reducing the release of its inhibitors. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin, a flavonoid like Quercetin, can stabilize mast cells and may enhance MCP-2 activity indirectly by reducing oxidative stress and inhibitory mediator release. | ||||||